Citation: B. Fisher et al., Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial, J NAT CANC, 93(9), 2001, pp. 684-690
Authors:
Burbee, DG
Forgacs, E
Zochbauer-Muller, S
Shivakumar, L
Fong, K
Gao, BN
Randle, D
Kondo, M
Virmani, A
Bader, S
Sekido, Y
Latif, F
Milchgrub, S
Toyooka, S
Gazdar, AF
Lerman, MI
Zabarovsky, E
White, M
Minna, JD
Citation: Dg. Burbee et al., Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression, J NAT CANC, 93(9), 2001, pp. 691-699
Authors:
Done, SJ
Eskandarian, S
Bull, S
Redston, M
Andrulis, IL
Citation: Sj. Done et al., p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast, J NAT CANC, 93(9), 2001, pp. 700-704
Authors:
Dorgan, JF
Baer, DJ
Albert, PS
Judd, JT
Brown, ED
Corle, DK
Campbell, WS
Hartman, TJ
Tejpar, AA
Clevidence, BA
Giffen, CA
Chandler, DW
Stanczyk, FZ
Taylor, PR
Citation: Jf. Dorgan et al., Serum hormones and the alcohol-breast cancer association in postmenopausalwomen, J NAT CANC, 93(9), 2001, pp. 710-715
Citation: Dg. Evans et al., Re: Characterization of hereditary nonpolyposis colorectal cancer familiesfrom a population-based series of cases, J NAT CANC, 93(9), 2001, pp. 716-717
Citation: H. Anton-culver et al., Re: Characterization of hereditary nonpolyposis colorectal cancer familiesfrom a population-based series of cases - Response, J NAT CANC, 93(9), 2001, pp. 717-717